Report Id: SNS/HC/1042 | May 2022 | Region: Global | 125 Pages
The worldwide ECG Equipment and Management System market is anticipated to arrive at USD 9.77 billion by 2028. From 2022 to 2028, the market is assessed to develop at a CAGR of 6.38%. During the forecast time frame, the rising pervasiveness of cardiovascular arrhythmia and mechanical enhancements are supposed to drive market development.
The growing elderly population is likely to be a major driver of the ECG equipment and management system market. The National Institute on Aging (NIA), which is part of the National Institutes of Health, estimates that 8.5 percent of the world's population (617 million) is 65 or older. In 2017, 25.7 percent of Europe's population was 60 or older, with that number expected to rise to 32.2 percent by 2050.
Diabetes and cardiovascular disease risk rise with age, resulting in a higher prevalence of both diseases in persons aged 60 and up. According to research published by the American Heart Association in 2016, around 85.6 million adults in the United States suffer from one or more cardiovascular illnesses, including approximately 43.7 million adults over the age of 60.
The important reasons supporting ECG market share growth are technological advances in ECG devices.
An increase in the demand for ECG is due to an increase in the number of ECG examinations performed for those at risk of cardiac illness.
The fierce competition between the sellers in this market
A huge number of product recalls and low reimbursement rates for cardiovascular disorders
The increased use of monitoring equipment due to the aging population and advances in imaging modalities
A scarcity of qualified electrocardiograph operators
Impact Of COVID-19 Analysis
Covid-19 has had an impact on the Electrocardiograph market, resulting in a considerable decline in Electrocardiograph sales due to a lack of visits to healthcare facilities such as hospitals and clinics. The proliferation of the coronavirus has an impact on workforce and staffing difficulties, as well as the prioritization of procedures. These factors have influenced the Electrocardiograph market by causing primary care appointments to be canceled in hospitals and reflecting patients' fears of infection.
The ECG equipment and management systems market is going to be estimated by a CAGR of 6.38% from 2022 to 2028 with a forecast period of USD 9.77 billion by 2028.
KEY Market segment
Resting ECG System
Stress ECG Monitors
Event Monitoring Systems
ECG Management Systems
Hospitals & Clinics
BioTelemetry Inc, CompuMed, Inc, Mindray Medical, Hill Rom, Nihon Kohden Corporation, McKesson Corporation, Drägerwerk AG & Co. KGaA Mindray Bio-Medical Electronics Co Ltd, Meditech Equipment Co Ltd, Schiller AG, Spacelabs Healthcare, Device Technologies, ZOLL Medical Corporation, Medical ECONET GmbH, GE Healthcare, Koninklijke Philips N.V, CardioComm Solutions, Inc.
Because of the high prevalence of cardiovascular illnesses, higher healthcare expenditure, and a large senior population base, the North American electrocardiograph market dominated the global ECG market in 2021 furthermore, is probably going to keep on doing as such during the forecast time frame.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2021||US$ xx Billion|
|Market Size by 2028||US$ 9.77 Billion|
|CAGR||CAGR of 6.38% From 2022 to 2028|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Type (Holter Monitors, Resting ECG System, Stress ECG Monitors, Event Monitoring Systems, ECG Management Systems)
• By End-Use (Hospitals & Clinics, Ambulatory Facilities, Others)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||BioTelemetry Inc, CompuMed, Inc, Mindray Medical, Hill Rom, Nihon Kohden Corporation, McKesson Corporation, Drägerwerk AG & Co. KGaA Mindray Bio-Medical Electronics Co Ltd, Meditech Equipment Co Ltd, Schiller AG, Spacelabs Healthcare, Device Technologies, ZOLL Medical Corporation, Medical ECONET GmbH, GE Healthcare, Koninklijke Philips N.V, CardioComm Solutions, Inc.|
|DRIVING FACTORS||• The important reasons supporting ECG market share growth are technological advances in ECG devices.
• An increase in the demand for ECG is due to an increase in the number of ECG examinations performed for those at risk of cardiac illness.
|OPPORTUNITIES||• The fierce competition between the sellers in this market
• A huge number of product recalls and low reimbursement rates for cardiovascular disorders
Frequently Asked Questions (FAQ) :
key drivers of the ECG Equipment and Management Systems Market is Increase in the demand for ECG due to an increase in the number of ECG examinations performed for those at risk of cardiac illness.
The challenge faced by the 3D Printed Wearables Market is a scarcity of qualified electrocardiograph operators.
The market is divided into two segments and the segments are by product type and by End-user.
North America had the greatest revenue share of the worldwide ECG Equipment and Management Systems market.
The worldwide ECG Equipment and management system market is anticipated to arrive at USD 9.77 billion by 2028.
Table of Contents:
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID 19 Impact Analysis
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Global ECG Equipment and Management Systems Market Segmentation, by Type
8.1 Holter Monitors
8.2 Resting ECG System
8.3 Stress ECG Monitors
8.4 Event Monitoring Systems
8.5 ECG Management Systems
9. Global ECG Equipment and Management Systems Market Segmentation, by End-Use
9.1 Hospitals & Clinics
9.2 Ambulatory Facilities
10. Regional Analysis
10.2 North America
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4.2 South Korea
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.3 South Africa
10.6 Latin America
10.6.3 Rest of Latin America
11. Company Profiles
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 GE Healthcare
11.3 CompuMed, Inc.
11.4 Schiller AG
11.5 Mindray Medical
11.6 Hill Rom
11.7 Nihon Kohden Corporation
11.8 Koninklijke Philips N.V.
11.9 Spacelabs Healthcare
11.10 McKesson Corporation
11.11 Drägerwerk AG & Co. KGaA
11.12 Mindray Bio-Medical Electronics Co., Ltd.
11.13 CardioComm Solutions, Inc.
11.14 Meditech Equipment Co., Ltd.
11.15 Device Technologies
11.16 ZOLL Medical Corporation
11.17 Medical ECONET GmbH.
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share analysis
12.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of a good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach a stage wherein we can provide our clients best and most accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research as the name suggests is a research process wherein, we collect data through readily available information. In this process, we use various paid and unpaid databases to which our team has access and gather data through the same. This includes examining listed companies’ annual reports, Journals, SEC filling, etc. Apart from this, our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various universities as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content-specific facts that can be sued to solve specific problems. Since the collected data is fresh and first-hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply sides of the industry to make sure we land an accurate judgment and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses, and observation of on-field participants. The below-mentioned chart should give a better understanding of part 1 of the primary interview.
Part 2: In this part of the primary research the data collected via secondary research and part 1 of the primary research is validated with the interviews with individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence center, our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real-time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but is not limited to getting rid of the many typos, duplication of numbers, or missing any important information. The people involved in this process include technical content writers, research heads, and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.